What is the cause and treatment for seborrheic dermatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Seborrheic Dermatitis: Cause and Treatment

Cause

Seborrheic dermatitis results from an inflammatory response to Malassezia yeast species that colonize sebum-rich areas of the skin. 1, 2 The pathophysiology involves Malassezia metabolizing sebum triglycerides into irritating free fatty acids that trigger inflammation, combined with immune dysregulation and skin barrier dysfunction. 2, 3

  • The condition affects areas with high sebaceous gland density: scalp, face (especially nasolabial folds, eyebrows, retroauricular areas), central chest, back, and body folds. 4, 3
  • Malassezia ovale (Pityrosporum ovale) is the primary organism implicated, though the exact mechanism remains incompletely understood. 5, 6
  • The disease is more pronounced in patients with HIV infection, Parkinson's disease, and Down syndrome. 2

Treatment Approach

The most effective treatment combines topical antifungal medications to reduce Malassezia yeast with topical anti-inflammatory agents to control inflammation and itching. 1

First-Line Therapy: Topical Antifungals

Topical ketoconazole is the mainstay of therapy for seborrheic dermatitis of the face and body. 5, 4

  • For facial and body involvement: Apply ketoconazole 2% cream twice daily for four weeks or until clinical clearing. 5
  • For scalp involvement: Use antifungal shampoos as first-line therapy, with ketoconazole being highly effective. 4, 6
  • Ketoconazole works by impairing ergosterol synthesis in fungal cell membranes and reducing Malassezia colonization. 5
  • Other effective topical antifungals include ciclopirox, terbinafine, and bifonazole. 6

Second-Line Therapy: Anti-Inflammatory Agents

Low-potency topical corticosteroids should be used only for short-term control of inflammation and itching. 1, 2

  • Use the least potent preparation required to control symptoms. 1
  • Critical caveat: Avoid long-term use of topical corticosteroids, especially on the face, due to risk of skin atrophy, telangiectasia, and tachyphylaxis. 1, 2
  • Topical calcineurin inhibitors (tacrolimus, pimecrolimus) can be used as steroid-sparing alternatives for short-term use. 4, 3

Supportive Care

Gentle skin care with mild, non-soap cleansers and emollients helps reduce dryness and scaling. 1, 2

  • Use dispersible creams as soap substitutes, as soaps remove natural lipids from the skin surface. 1
  • Apply emollients after bathing to provide a surface lipid film that retards evaporative water loss. 1
  • For facial seborrheic dermatitis: Avoid alcohol-containing preparations as they increase skin dryness. 1, 2
  • Use non-greasy moisturizers with urea or glycerin applied after bathing. 1

Adjunctive Therapy

  • For moderate to severe pruritus: Oral antihistamines (cetirizine, loratadine, fexofenadina) can provide symptomatic relief. 1
  • Antihistamines with sedative properties are useful as short-term adjuvants during severe flares with intense pruritus. 1
  • For scalp involvement: Coal tar preparations can reduce inflammation and scaling. 1

Systemic Therapy for Severe or Resistant Cases

Oral antifungals are reserved for widespread or treatment-resistant seborrheic dermatitis. 6, 7

  • Itraconazole: 200 mg/day for the first week of the month, then 200 mg/day for the first 2 days monthly for 2-11 months. 7
  • Terbinafine: 250 mg/day either continuously for 4-6 weeks or intermittently (12 days per month) for 3 months. 7
  • Fluconazole: 50 mg/day for 2 weeks or 200-300 mg weekly for 2-4 weeks. 7
  • Ketoconazole oral therapy is associated with more relapses compared to other systemic antifungals. 7

Treatment Duration and Maintenance

Treatment should be continued for the full prescribed duration even if symptoms improve sooner. 2

  • Facial and body lesions typically require 2-4 weeks of treatment. 5
  • Due to the chronic, relapsing nature of seborrheic dermatitis, maintenance therapy with emollients and intermittent anti-inflammatory treatment may be necessary. 2
  • Long-term antifungal shampoos can be used for maintenance of scalp involvement. 4

Common Pitfalls to Avoid

  • Do not use neomycin in topical preparations due to risk of sensitization. 1
  • Distinguish seborrheic dermatitis from psoriasis, atopic dermatitis, and contact dermatitis, which require different treatment approaches. 1, 2
  • Avoid undertreatment due to fear of steroid side effects, but equally avoid overuse of corticosteroids. 1
  • Treat secondary bacterial infection with appropriate antibiotics if present (look for crusting, weeping, or purulent exudate). 1
  • Non-sedating antihistamines have little value in seborrheic dermatitis and should not be overused. 1

References

Guideline

Treatment Options for Seborrheic Dermatitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Seborrheic Dermatitis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Current Understanding of Seborrheic Dermatitis: Treatment Options.

Journal of cutaneous medicine and surgery, 2025

Research

Diagnosis and treatment of seborrheic dermatitis.

American family physician, 2015

Research

Role of antifungal agents in the treatment of seborrheic dermatitis.

American journal of clinical dermatology, 2004

Research

Systematic review of oral treatments for seborrheic dermatitis.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.